...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trillium
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Agreed 100%.

I'd be happy with a $10 CVR deal with more to come based on milestones.

As fouremm has pointed out Don has proven (over and over again) he is not qualified to run a public company. I would add that biotech is far too sophisticated for Don.

I hope something happpens soon. It's been 7 years of very promising science and zero business success. It is so pathetic it almost makes me laugh. Guys like SanFran flammed out   :)

GLTA

Toinv

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply